Bright Minds Biosciences Inc (DRUG.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
(Values in thousands)
| 09-2020 | |
| Assets | |
| Current Assets | |
| Cash & Cash Equivalents | 800 |
| TOTAL | $878 |
| Non-Current Assets | |
| Intangibles | 2 |
| TOTAL | $2 |
| Total Assets | $880 |
| Liabilities | |
| Current Liabilities | |
| Accounts payable and accrued liabilities | 138 |
| Accrued Expenses | 13 |
| TOTAL | $151 |
| Non-Current Liabilities | |
| TOTAL | $0 |
| Total Liabilities | $151 |
| Shareholders' Equity | |
| Common Shares | 981 |
| Retained earnings | -559 |
| Other shareholders' equity | 308 |
| TOTAL | $729 |
| Total Liabilities And Equity | $880 |